U.S. Entertainment Stock News

Dollar Tree recently entered into a US$500 million term loan credit facility maturing in March 2029, with interest tied to the Term SOFR Rate plus 1.00%, flexible prepayment, and covenants linked to leverage and fixed charge coverage ratios. The new financing, combined with ongoing investment in rebuilt and newly acquired distribution centers and cloud-based supply chain technology, underscores management’s emphasis on upgrading infrastructure and inventory management capabilities. We’ll now...

Why Rumble’s CFO change matters for investors Rumble (RUM) is reshaping its senior team, bringing in former Intel executive Mike Masci as CFO on March 31, 2026, while outgoing CFO Brandon Alexandroff shifts into an advisor role. For you as an investor, this type of leadership change can affect how the company balances cash needs, growth investments, and potential capital allocation decisions, including its AI and cloud infrastructure plans. See our latest analysis for Rumble. Rumble’s latest...

In March 2026, Rambus Inc. insiders, including executives Seraphin Luc and John Shinn, sold more than US$4.60 million of stock, prompting renewed scrutiny of management’s intentions and timing. This wave of insider selling has become a focal point for investors already watching semiconductor sector weakness and questioning how closely leadership’s actions align with Rambus’s long-term positioning in AI-focused memory solutions. We’ll now examine how this recent insider selling flurry...

If you are wondering whether Ascendis Pharma's share price still offers value after a strong run, the key is to look closely at what the current valuation actually reflects. The stock last closed at US$228.73, with returns of 6.1% over 7 days, a 2.0% decline over 30 days, 7.2% year to date, 51.0% over 1 year, 220.2% over 3 years and 73.7% over 5 years. Recent price moves have come alongside ongoing attention on Ascendis Pharma's pipeline progress and funding position, as investors reassess...

WEBTOON Entertainment Inc. recently announced that its regional CANVAS user-generated content services will be unified into a single global platform in 2026, supporting distribution in seven languages and introducing expanded creator monetization tools, analytics, and AI-assisted translation. This move signals an effort to lower language and distribution barriers for creators while deepening reader personalization, potentially increasing creator engagement and strengthening WEBTOON’s...

Recently, Deutsche Bank reiterated a Hold rating on Kimberly-Clark while Britain’s competition regulator began a phase 1 review of its US$3.40 billion Suzano joint venture, with a decision expected by May 28. At the same time, modest 2.5% organic sales growth and a five‑percentage‑point drop in free cash flow margin have raised fresh questions about Kimberly-Clark’s core profitability and capital needs. We’ll now examine how concerns over slowing organic sales and weaker free cash flow...

Capital raise potential and what it could mean for XPLR Infrastructure (XIFR) XPLR Infrastructure (XIFR) has filed a US$300 million shelf registration for its common units, giving the partnership flexibility to issue equity as funding needs or investment plans emerge. See our latest analysis for XPLR Infrastructure. The shelf filing comes as XIFR’s share price sits at US$10.62, with a 1 day share price return of 4.94% and a 1 year total shareholder return of 13.83%. The 3 year total...

MARA Holdings recently sold 15,133 Bitcoin between March 4 and March 25, 2026, raising about US$1.10 billion to repurchase roughly US$1.00 billion of its 2030 and 2031 convertible notes, cutting its Bitcoin holdings by around 28%. This large balance-sheet move, described by one hedge fund CIO as “distressed selling,” raises fresh questions about financial flexibility and sector-wide pressures in Bitcoin mining. Next, we’ll examine how this sizable Bitcoin liquidation and debt reduction...

NiSource (NI), a regulated natural gas and electric utility, is back in focus after recent share price moves that contrast a small decline over the past month with a stronger total return over the past 3 months and 1 year. See our latest analysis for NiSource. The recent 7 day share price return of 2.15% builds on a 90 day share price return of 11.73%. The 1 year total shareholder return of 18.68% sits alongside a 3 year total shareholder return of 85.44% and a 5 year total shareholder return...

Alnylam Pharmaceuticals has reported new clinical and real world data on its RNAi therapy vutrisiran in ATTR-CM, highlighting durable benefits in quality of life and reductions in advanced disease progression and mortality. The company has also shared pooled Phase 2 safety data for zilebesiran that supports its move into a global Phase 3 trial in hypertension and cardiovascular risk reduction. For investors tracking NasdaqGS:ALNY, this update centers on the company’s core RNAi franchise and...

Dollar General (NYSE:DG) has removed over 1,500 SKUs from its assortment as part of a broad simplification effort. The company is testing a new store format that pairs a leaner product mix with refreshed layouts. Existing locations are being renovated to align with the updated format and merchandising approach. Dollar General operates as a discount retailer focused on everyday essentials, often in smaller communities and value oriented shopping areas. The current SKU reduction and store...

Elanco Animal Health (NYSE:ELAN) is presenting at the World Vaccine Congress 2026. Senior leadership is discussing the company’s product development in animal vaccines. The appearance places Elanco alongside major global vaccine developers and industry experts. For you as an investor following NYSE:ELAN, this conference appearance ties directly to the company’s core focus on animal health products, including vaccines for livestock and companion animals. The World Vaccine Congress 2026 is a...

UP Fintech Holding Limited recently reported its fourth-quarter and full-year 2025 results, with Q4 revenue of US$175.57 million and net income of US$45.23 million, and full-year revenue of US$612.06 million and net income of US$170.9 million, all higher than the prior year. The sharp rise in basic earnings per share from continuing operations to US$0.96 for 2025, up from US$0.375 a year earlier, highlights a significant improvement in profitability. We will now examine how this strong...

Geopolitical tensions linked to the Iran war are increasing the risk of disruptions to helium supplies, a critical input for semiconductor fabrication. Any sustained helium shortage or price shock could affect Lam Research's ability to support chipmakers that rely on its wafer fabrication equipment and services. Investors in NasdaqGS:LRCX are now weighing these supply chain risks alongside earnings, AI demand trends and valuation discussions. Lam Research, trading on NasdaqGS:LRCX at...

Coherent (COHR) is back in focus after its silicon photonics breakthrough and index inclusion helped fuel a rally, only for the stock to pull back as traders take profits and reassess execution risks. See our latest analysis for Coherent. That context helps explain why Coherent’s share price is at US$238.21 after a sharp 8.45% 1 day share price return, even as the 7 day share price return of 12.53% and 30 day share price return of 8% contrast with a 90 day share price return of 29.06% and a...

Georgia Power, a subsidiary of Southern (NYSE:SO), has started construction on a 260 MW battery energy storage system in Jefferson County, Georgia. The company is also planning two additional large scale solar plus storage projects totaling 350 MW. These projects were approved by the Georgia Public Service Commission and are aimed at supporting grid reliability and growing power demand. For investors tracking NYSE:SO, this move adds context to a stock that has returned 10.7% year to date...

Wondering if Aramark at around US$40.54 is giving you fair value or leaving money on the table? This article walks through what that price could mean for you as an investor. The stock has delivered a 17.1% return over the last year and 10.8% year to date, with a 0.8% move over the past week and a 3.1% decline across the last month, which may change how you think about its risk and reward trade off. Recent coverage has focused on Aramark's position as a major player in food, facilities, and...

Huntington Bancshares (HBAN) has been in focus after joining a tokenized deposit network built on ZKsync infrastructure and selecting the SEI Wealth Platform to upgrade and unify its wealth management systems. See our latest analysis for Huntington Bancshares. Those tech-focused moves come after a mixed stretch for Huntington's shares, with a 4.19% 1 day share price return and a 10.47% decline year to date. At the same time, the 3 year total shareholder return of 62.84% points to stronger...

Shareholder activism around General Electric (GE) is in focus after JLens and the Anti Defamation League urged investors to vote against a proposal targeting GE Aerospace’s defense ties with Israel at the upcoming annual meeting. See our latest analysis for General Electric. Recent activism around GE’s defense exposure comes after a sharp pullback, with a 30 day share price return of negative 17.09% and year to date share price return of negative 11.53%. However, the 5 year total shareholder...

Taylor Morrison Home (NYSE:TMHC) reports a significantly smaller backlog of homes, pointing to softer order trends. The company also signals anticipated sales declines, raising questions about demand conditions across its communities. These updates spotlight possible broader pressures across the U.S. homebuilding sector, including pricing power and buyer confidence. Taylor Morrison Home, a major U.S. homebuilder focused on single family and community developments, now sits with a much...

Wondering if National Health Investors is priced fairly today or if the current share price leaves some room on the table? This overview walks through what the recent numbers may be saying about value. The stock closed at US$80.86, with returns of 5.2% year to date and 14.2% over the last year, while the past 7 and 30 days have seen declines of 2.1% and 3.8% respectively. Recent coverage has focused on how real estate investment trusts are responding to changing conditions in healthcare...

Wondering if Avis Budget Group at around US$145.85 is still offering value after its recent run, or if you might be looking at a stock that has already priced in the good news? The share price sits at US$145.85, with returns of 18.0% over the last 7 days, 52.4% over the last 30 days, 13.7% year to date, 90.0% over 1 year and 103.7% over 5 years, while the 3 year return is a 13.7% decline. Recent price strength has arrived alongside ongoing interest in travel and mobility services, putting...

Johnson & Johnson (NYSE:JNJ) has entered a US$500 million R&D co-funding agreement with Royalty Pharma. The partnership is focused on advancing JNJ-4804, a first in class co-antibody therapy targeting IL-23 and TNF pathways. The therapy is being developed for chronic immune mediated diseases within J&J's immunology franchise. For investors watching NYSE:JNJ, this move highlights how central immunology remains to the company’s long term plan. J&J already has an active presence in immune...

Vornado Realty Trust announced that Meta signed a 10-year lease for its Meta Lab New York flagship, taking the entire five-level, 15,000-square-foot townhouse at 697 Fifth Avenue, adjacent to the St. Regis Hotel, in Manhattan. This long-term flagship commitment by a major technology brand highlights ongoing demand for high-profile Fifth Avenue retail space within Vornado’s Manhattan portfolio. Next, we’ll examine how securing Meta’s Fifth Avenue flagship as a long-term tenant could influence...